Drug Trial Radar · NCT02641769
Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.
Last checked: Nov 19, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jan 2014
Primary completion
Jun 2030
Study completion Jan 2031
Sponsor
- Lead sponsor
- Stem Cells ArabiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 29, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 21 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label, single arm, single center investigation to assess the safety and efficacy of purified adult autologous, bone marrow derived, highly specialized, differentiation specific into spermatogonial lineages, and mesenchymal stem cells injected into the seminiferous tubules and testis, through a 24-month follow-up period. The investigators' selected model of research is based on maximizing the efficiency of the approach by choosing an autologous pattern which preserves the genetic make-up of an individual that is vital in infertility conditions. Additionally, the approach involves injecting a combination of different but purified cell types which all aid in the re-establishment of spermatogenesis, and the generation of mature spermatozoa. Expected outcomes of this study are defined in general improvements in infertile patients with regards to testicular morphology, sexual function, semen quality, development of primary or secondary spermatocytes, spermatids, or mature spermatozoa in the testis, seminiferous tubules, or semen.
Conditions
- Non-obstructive Azoospermia
Interventions
Stem Cell TransplantationBiological
intervention with transplantation of autologous purified stem cells
Primary outcomes
What the sponsor says the trial is designed to measure.
- Appearance of spermatozoa in different maturation stages including primary spermatocytes, spermatids, and mature spermatozoa. Samples to be tested are either seminal fluid or testicular tissue obtained via fine needle aspiration (FNA) or surgical means.Time frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stem Cells of Arabia
Amman, Amman Governorate, Jordan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.